Positively Aware

The leading nonprofit #HIV / #AIDS treatment and care magazine. Published in Chicago by @TPANetwork. LIVE LIFE POSITIVELY AWARE.

[Positively Aware @PosAware]

@adapadvocacy @NarrPowerInst https://t.co/pACutnKOf5

[Positively Aware @PosAware]

Who gets a say in funding decisions that shape the HIV response? As federal funding shifts and other funders change their grantmaking, advocates say the communities most affected are losing their seat at the table.
https://t.co/5etqzknFTO

[Positively Aware @PosAware]

“Black women do not acquire #HIV because they lack information. More often they are navigating circumstances where the power to protect their health through safety resources and access to care is limited or denied,” writes Michelle Anderson @NarrPowerInst.
https://t.co/JLKG5Jcnjc

[Positively Aware @PosAware]

@NIH tells ACTG, @HIVptn, @HelpEndHIV, @IMPAACTNetwork they should “pause” new clinical trials amidst funding delays. Advocates have issued an open letter to Congress which the public can sign by Oct. 15.
https://t.co/GJbHIAErty

[Positively Aware @PosAware]

Fiji faces an HIV emergency. Shared syringes are driving new acquisitions, and experts say needle-exchange programs are essential to the response. Read how harm reduction, peer support and stigma-free care can help.
https://t.co/E40C40Dssd

[Positively Aware @PosAware]

What could November’s midterm elections mean for people living with and affected by #HIV? From Ryan White and Medicaid to PrEP, housing and global aid, POSITIVELY AWARE examines what could change, what might not and why your vote matters.
https://t.co/WcWKdW3j2O

[Positively Aware @PosAware]

“I’m from the ‘Never Surrender’ School.”
In a candid Q&A with @TimMurphyNYC for @PosAware, Lynda Dee talks about today’s threats to @NIH funding, the future of #HIV clinical trial networks and the personal losses that sparked nearly 4 decades of activism.
https://t.co/0h3DqNArmg

[Positively Aware @PosAware]

Drug-resistant tuberculosis can be challenging, especially for people living with HIV. New resources from @TAGTeam_Tweets help people understand their medications, manage side effects and communicate with healthcare providers.
https://t.co/UqdqEuAviD

[Positively Aware @PosAware]

After @UHC responded to his open letter, Morris A. Singletary is asking for a clear path to coverage of his complete HIV treatment. In his follow-up for Positively Aware, Morris reflects on what the insurer’s response means—and the questions that remain.
https://t.co/uwsrVXLq99

[Positively Aware @PosAware]

Take your picture for #adaywithhiv, then go to https://t.co/dTrqcOtSjX to upload it and a caption. A selection of uploaded images will appear in a special section of the NOV+DEC issue of Positively Aware—6 pictures will appear on three different versions of the foldout cover.

[A Day with HIV @A_Day_With_HIV]

A Day with HIV portrays 24 hours in the lives of people affected by #HIV—that’s all of us. This Tuesday (9/22), photograph a moment of your day. Post it to your social media w/a caption that includes the TIME, LOCATION & WHAT INSPIRED YOU to take it; add the hashtag #adaywithhiv.

[Positively Aware @PosAware]

Get in the picture this Tuesday, September 22 for A Day with HIV, Positively Aware’s annual anti-stigma campaign. The idea is to portray 24 hours in the lives of people affected by HIV—that’s all of us, regardless of status.
#adaywithhiv #hiv #stigma

[Positively Aware @PosAware]

5 long-term survivors of #HIV—Alfredo Trejo III, PhD, Malcolm Reid, Pollux López, Stewart Nelson-Reid and Toi Washington-Reynolds—talk with @RickGuasco for #ThePAChat about life after diagnosis and advocating for themselves & their communities.
https://t.co/D5CbuvUhmD

[Rick Guasco @RickGuasco]

Taking my #HIV medication after recording a video for @PosAware and the magazine’s annual anti-stigma campaign, @A_Day_With_HIV.

[Positively Aware @PosAware]

“HIV treatment has moved forward. I’m asking my insurer to move with it.”
In this essay for the magazine, Morris Singletary calls on his new insurer @UHC for timely access to treatment, transparency and recognition of the person behind the request.
https://t.co/AxWbhSVtQe

[Positively Aware @PosAware]

The exact amount of federal funding defense officials are attempting to divert from @NIH infectious disease research is unknown, but @rosadelauro says it’s in the billions. The agreement to transfer the funds has not been made public.
https://t.co/DA4oSvquD5

[Positively Aware @PosAware]

Respondents to @glaad’s #HIV #stigma survey recognized that HIV stigma exists, but the report found that knowledge of HIV has stagnated or even declined, driven by a lack of reliable information and visibility of HIV in media.
https://t.co/CkEeScnO0s

[Positively Aware @PosAware]

Julene Tripp Weaver talks about her experience on a clinical trial that led to @FDA approval of the new #HIV drug #Bixlenvo, for people who are virally suppressed on complex HIV treatment.
https://t.co/IOGuzp4pkB via @YouTube

[Positively Aware @PosAware]

Two clinical trial participants talk with @PosAware about their experience with the new FDA-approved HIV drug #Bixlenvo, a once-daily 2-drug pill for heavily treatment-experienced people whose #HIV is suppressed but on complex regimens. #ThePAchat
https://t.co/L2tiCPKhgv

[Positively Aware @PosAware]

“It represents another important step forward in the evolution of 2-drug regimens, offering heavily treatment-experienced people with #HIV and those on complex ART regimens an opportunity to simplify to a potent two-drug regimen,” says one HIV specialist.
https://t.co/2aK6bz3lVC

[Positively Aware @PosAware]

A new HIV stigma study from @GLAAD finds 31% of Gen Z adults feel knowledgeable about HIV. Tymia Ballard says, “telling young people to just educate themselves means very little if we are not thinking seriously about where that education is coming from.”
https://t.co/IIlpuIf3Uq